Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kroger

Showing results (251-260 of 277) with videos related to

Pageof 28
Sort By:
Histopathology|February 29, 2024
Liquid biopsy-based circulating tumour (ct)DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable resultsDouglas A Mata, Jessica K Lee, Vignesh Shanmugam, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 9, 2018
Family Mismatched Allogeneic Stem Cell Transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of European Society for Blood and Marrow TransplantationKavita Raj, Diderik-Jan Eikema, Donal P McLornan, et al.
Transplantation and Cellular Therapy|September 20, 2021
Post-Transplantation Cyclophosphamide for Graft-versus- Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison by Donor Type. A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow TransplantationFiroozeh Sahebi, Dirk-Jan Eikema, Linda Koster, et al.
Genome Biology|October 16, 2020
Clonal tracing reveals diverse patterns of response to immune checkpoint blockadeShengqing Stan Gu, Xiaoqing Wang, Xihao Hu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 9, 2018
Allogeneic Hematopoietic Cell Transplantation in Patients Aged 50Years or Older with Severe Aplastic AnemiaCarmel Rice, Dirk-Jan Eikema, Judith C W Marsh, et al.
The Journal of Infectious Diseases|September 6, 2008
Antiviral activity of single-dose PRO 140, a CCR5 monoclonal antibody, in HIV-infected adultsJeffrey M Jacobson, Michael S Saag, Melanie A Thompson, et al.
Bone Marrow Transplantation|November 22, 2023
Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMTV Potter, L Gras, L Koster, et al.
Bone Marrow Transplantation|February 2, 2021
Thiotepa-busulfan-fludarabine (TBF) conditioning regimen in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis: an outcome analysis from the Chronic Malignancies Working Party of the EBMTGiorgia Battipaglia, Katya Mauff, Lotus Wendel, et al.
Science (New York, N.Y.)|November 6, 2025
The origin of hepatocellular carcinoma depends on metabolic zonationJason Guo, Roger Liang, Andrew Chung, et al.
Blood|May 25, 2006
Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow TransplantationRodrigo Martino, Rocio Parody, Takahiro Fukuda, et al.
Pageof 28

Showing results (251-260 of 277) with videos related to

Sort By:
Pageof 28
Histopathology|February 29, 2024
Liquid biopsy-based circulating tumour (ct)DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable resultsDouglas A Mata, Jessica K Lee, Vignesh Shanmugam, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 9, 2018
Family Mismatched Allogeneic Stem Cell Transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of European Society for Blood and Marrow TransplantationKavita Raj, Diderik-Jan Eikema, Donal P McLornan, et al.
Transplantation and Cellular Therapy|September 20, 2021
Post-Transplantation Cyclophosphamide for Graft-versus- Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison by Donor Type. A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow TransplantationFiroozeh Sahebi, Dirk-Jan Eikema, Linda Koster, et al.
Genome Biology|October 16, 2020
Clonal tracing reveals diverse patterns of response to immune checkpoint blockadeShengqing Stan Gu, Xiaoqing Wang, Xihao Hu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 9, 2018
Allogeneic Hematopoietic Cell Transplantation in Patients Aged 50Years or Older with Severe Aplastic AnemiaCarmel Rice, Dirk-Jan Eikema, Judith C W Marsh, et al.
The Journal of Infectious Diseases|September 6, 2008
Antiviral activity of single-dose PRO 140, a CCR5 monoclonal antibody, in HIV-infected adultsJeffrey M Jacobson, Michael S Saag, Melanie A Thompson, et al.
Bone Marrow Transplantation|November 22, 2023
Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMTV Potter, L Gras, L Koster, et al.
Bone Marrow Transplantation|February 2, 2021
Thiotepa-busulfan-fludarabine (TBF) conditioning regimen in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis: an outcome analysis from the Chronic Malignancies Working Party of the EBMTGiorgia Battipaglia, Katya Mauff, Lotus Wendel, et al.
Science (New York, N.Y.)|November 6, 2025
The origin of hepatocellular carcinoma depends on metabolic zonationJason Guo, Roger Liang, Andrew Chung, et al.
Blood|May 25, 2006
Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow TransplantationRodrigo Martino, Rocio Parody, Takahiro Fukuda, et al.
Pageof 28